PROTHROMBIN 20210 G: A MUTATION AND FACTOR V LEIDEN MUTATION IN WOMEN WITH A HISTORY OF SEVERE PREECLAMPSIA AND (H)ELLP SYNDROME*

REFERENCES

• Dekker G. A., de Vries J. I., Doelitzsch P. M., Huijgens P. C., von Blomberg B. M., Jakobs C., van Geijn H. P. Underlying Disorders Associated with Severe Early-Onset Preeclampsia. Am. J. Obstet. Gynecol. 1995; 173(4)1042–1048
   PubMed Web of Science ®Google Scholar
• Preston F. E., Rosendaal F. R., Walker I. D., Briet E., Berntorp E., Conard J., Fontcuberta J., Makris M., Mariani G., Noteboom W., Pabinger I., Legnani C., Scharrer I., Schulman S., van der Meer F. J. Increased Fetal Loss in Women with Heritable Thrombophilia. Lancet 1996; 348(9032)913–916
   PubMed Web of Science ®Google Scholar
• van Pampus M. G., Dekker G. A., Wolf H., Huijgens P. C., Koopman M. M., von Blomberg B. M., Buller H. R. High Prevalence of Hemostatic Abnormalities in Women with a History of Severe Preeclampsia. Am. J. Obstet. Gynecol. 1999; 180(5)1146–1150
   PubMed Web of Science ®Google Scholar
• Bertina R. M. Factor V Leiden and Other Coagulation Factor Mutations Affecting Thrombotic Risk. Clin. Chem. 1997; 43(9)1678–1683
   Google Scholar
• Howard T. E., Marusa M., Boisza J., Young A., Sequeira J., Channell C., Guy C., Benson E., Duncan A. The Prothrombin Gene 3′-Untranslated Region Mutation Is Frequently Associated with Factor V Leiden in Thrombophilic Patients and Shows Ethnic-Specific Variation in Allele Frequency. Blood 1998; 91(3)1092
   Google Scholar
• Ehrenforth S., Ludwig G., Klinke S., Krause M., Scharrer I., Nowak-Gottl U. The Prothrombin 20210 A Allele Is Frequently Coinherited in Young Carriers of the Factor V Arg 506 to Gln Mutation with Venous Thrombophilia. Blood 1998; 91(6)2209–2210
   Google Scholar
• Brenner B., Mandel H., Lanir N., Younis J., Rothbart H., Ohel G., Blumenfeld Z. Activated Protein C Resistance Can Be Associated with Recurrent Fetal Loss. Br. J. Haematol. 1997; 97(3)551–554
   Google Scholar
• Rotmensch S., Liberati M., Mittlemann M., Ben-Rafael Z. Activated Protein C Resistance and Adverse Pregnancy Outcome. Am. J. Obstet. Gynecol. 1997; 177(1)170–173
   Google Scholar
• Dizon-Townson D. S., Nelson L. M., Easton K., Ward K. The Factor V Leiden Mutation May Predispose Women to Severe Preeclampsia. Am. J. Obstet. Gynecol. 1996; 175(4 Pt. 1)902–905
   PubMedGoogle Scholar
• Dizon-Townson D. S., Meline L., Nelson L. M., Varner M., Ward K. Fetal Carriers of the Factor V Leiden Mutation Are Prone to Miscarriage and Placental Infarction. Am. J. Obstet. Gynecol. 1997; 177(2)402–405
   Google Scholar
• Grandone E., Margaglione M., Colaizzo D., d'Addedda M., Cappucci G., Vecchione G., Scianname N., Pavone G., Di Minno G. Factor V Leiden is Associated with Repeated and Recurrent Unexplained Fetal Losses. Thromb. Haemost. 1997; 77(5)822–824
   Google Scholar
• Meinardi J. R., Middeldorp S., de Kam P. J., Koopman M. M., van Pampus E. C., Hamulyák K., Prins M. H., Buller H. R., van der Meer J. Increased Risk for Fetal Loss in Carriers of the Factor V Leiden Mutation. Ann. Intern. Med. 1999; 130(9)736–739
   PubMed Web of Science ®Google Scholar
• Kupferminc M. J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., Fait G., Lessing J. B. Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy. N. Engl. J. Med. 1999; 340(1)9–13
   PubMed Web of Science ®Google Scholar
• Gris J. C., Qur I., Monpeyroux F., Mercier E., Ripart-Neveu S., Tailland M. L., Hoffet M., Berlan J., Daures J. P., Mares P. Case-Control Study of the Frequency of Thrombophilic Disorders in Couples with Late Foetal Loss and No Thrombotic Antecedent—The Nimes Obstetricians and Haematologists Study 5 (NOHA5). Thromb. Haemost. 1999; 81(6)891–899
   Google Scholar
• De Groot C. J., Bloemenkamp K. W., Duvekot E. J., Helmerhorst F. M., Bertina R. M., Van Der Meer F., De Ronde H., Oei S. G., Kanhai H. H., Rosendaal F. R. Preeclampsia and Genetic Risk Factors for Thrombosis: A Case-Control Study. Am. J. Obstet. Gynecol. 1999; 181(4)975–980
   PubMed Web of Science ®Google Scholar
• Sibai B. M. The HELLP Syndrome (Hemolysis, Elevated Liver Enzymes, and Low Platelets): Much Ado About Nothing?. Am. J. Obstet. Gynecol. 1990; 162(2)311–316
   PubMed Web of Science ®Google Scholar
• Poort S. R., Rosendaal F. R., Reitsma P. H., Bertina R. M. A Common Genetic Variation in the 3′-Untranslated Region of the Prothrombin Gene is Associated with Elevated Plasma Prothrombin Levels and an Increase in Venous Thrombosis. Blood 1996; 88(10)3698–3703
   PubMed Web of Science ®Google Scholar
• Voorberg J., Roelse J., Koopman R., Buller H., Berends F., ten Cate J. W., Mertens K., van Mourik J. A. Association of Idiopathic Venous Thromboembolism with Single Point-Mutation at Arg506 of Factor V. Lancet 1994; 343(8912)1535–1536
   PubMedGoogle Scholar
• Rosendaal F. R., Siscovick D. S., Schwartz S. M., Psaty B. M., Raghunathan T. E., Vos H. L. A Common Prothrombin Variant (20210 G to A) Increases the Risk of Myocardial Infarction in Young Women. Blood 1997; 90(5)1747–1750
   Google Scholar
• Rosendaal F. R., Siscovick D. S., Schwartz S. M., Beverly R. K., Psaty B. M., Longstreth W. T., Jr., Raghunathan T. E., Koepsell T. D., Reitsma P. H. Factor V Leiden (Resistance to Activated Protein C) Increases the Risk of Myocardial Infarction in Young Women. Blood 1997; 89(8)2817–2821
   PubMed Web of Science ®Google Scholar
• Doggen C. J., Cats V. M., Bertina R. M., Rosendaal F. R. Interaction of Coagulation Defects and Cardiovascular Risk Factors: Increased Risk of Myocardial Infarction Associated with Factor V Leiden or Prothrombin 20210A. Circulation 1998; 97(11)1037–1041
   PubMed Web of Science ®Google Scholar
• Arruda V. R., Siquiera L. H., Chiaparini L. C., Coelho O. R., Mansur A. P., Ramires A., Annichino-Bizzacchi J. M. Prevalence of the Prothrombin Gene Variant 20210 G→A Among Patients with Myocardial Infarction. Cardiovasc. Res. 1998; 37(1)42–45
   Google Scholar